The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
about
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
description
clinical trial
@en
klinisch onderzoek
@nl
name
The Pharmacokinetics, Safety, ...... dren Less Than 12 Years of Age
@en
type
label
The Pharmacokinetics, Safety, ...... dren Less Than 12 Years of Age
@en
prefLabel
The Pharmacokinetics, Safety, ...... dren Less Than 12 Years of Age
@en
P4844
P1476
Phase I/II Study of the Pharma ...... dren Less Than 12 Years of Age
@en
P3098
NCT03760458
P580
2019-04-01T00:00:00Z
P582
2021-02-28T00:00:00Z